臨床婦人科産科75巻3号

2021年04月発行

今月の臨床 女性のライフステージごとのホルモン療法―この1冊ですべてを網羅する 腫瘍

外科的閉経

著者： 佐々木浩¹

所属機関： ¹大阪医科薬科大学産婦人科学教室

ページ範囲：P.369 - P.375

●外科的閉経は骨粗鬆症，脂質異常症，心血管リスクの発症リスクが増加するだけでなく死亡リスクも上昇することから，特に45歳未満での外科的閉経患者に対しては積極的にホルモン補充療法（HRT）を行うべきである．

●婦人科悪性腫瘍治療により外科的閉経をきたした場合はがん治療後管理だけでなくHRTを含めた術後のトータルヘルスケアが重要である．

●子宮内膜症治療後の外科的閉経ではHRTによる内膜症再発リスクを伴うこともあり，内膜症の状態，子宮の有無，閉経年齢，症状などを勘案しHRTを施行するかを検討する．

参考文献

1）Madalinska JB, et al : Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 23 : 6890-6898, 2005

2）Wilson LF, et al : Hot flushes and night sweats symptom profiles over a 17-year period in mid-aged women : The role of hysterectomy with ovarian conservation. Maturitas 91 : 1-7, 2016

3）Rocca WA, et al : Accelerated accumulation of multimorbidity after bilateral oophorectomy : a population-based cohort study. Mayo Clin Proc 91 : 1577-1589, 2016

4）Rocca WA, et al : Oophorectomy, estrogen, and dementia : a 2014 update. Mol Cell Endocrinol 389 : 7-12, 2014

5）Yoshida T, et al : Impact of surgical menopause on lipid and bone metabolism. Climacteric 14 : 445-452, 2011

6）Vesco KK, et al : Surgical menopause and nonvertebral fracture risk among older US women. Menopause 19 : 510-516, 2012

7）Atsma F, et al : Postmenopausal status and early menopause as independent risk factors for cardiovascular disease : a meta-analysis. Menopause 13 : 265-279, 2006

8）Parker WH, et al : Eunice Chang,Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses'health study. Obstet Gynecol 113 : 1027-1037, 2009

9）Kingsberg SA, et al : Clinical effects of early or surgical menopause. Obstet Gynecol 135 : 853-868, 2020

10）Lacey JV, et al : Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 77 : 149-154, 2000

11）Shim SH, et al : Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors : a meta-analysis. Eur J Cancer 50 : 1628-1637, 2014

12）Rees M, et al : European Menopause and Andropause Society（EMAS）and International Gynecologic Cancer Society（IGCS）position statement on managing the menopause after gynecological cancer : focus on menopausal symptoms and osteoporosis. Maturitas 134 : 56-61, 2020

13）Sinno AK, et al : Hormone therapy（HT）in women with gynecologic cancers and in women at high risk for developing a gynecologic cancer : A Society of Gynecologic Oncology（SGO） clinical practice statement : this practice statement has been endorsed by The North American Menopause Society. Gynecol Oncol 157 : 303-306, 2020

14）Matorras R, et al : Recurrence of endometriosis in women with bilateral adnexectomy（with or without total hysterectomy） who received hormone replacement therapy. Fertil Steril 77 : 303-308, 2002

15）Belchetz PE : Hormonal treatment of postmenopausal women. N Engl J Med 330 : 1062-1071, 1994